Stay updated on Psilocybin for Alcohol Use Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.

Latest updates to the Psilocybin for Alcohol Use Disorder Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record. This blocks access to the core content and associated trial details on the page.SummaryDifference20%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, representing a new revision of the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a new revision number, updating from v3.6.4 to v3.6.5, indicating a minor update to the page’s underlying systems or documentation. This update does not appear to modify the study content or displayed data.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now includes updated study metadata: the site is listed as Psychiatric Centre Rigshospitalet, and the principal investigator is Anders Fink-Jensen, MD, DMSci, with the verification date noted as 2024-07 and the last verified status listed as Unknown. These details clarify who is responsible for the study and where it is conducted.SummaryDifference0.5%

- Check60 days agoChange DetectedThe page’s revision tag updated from v3.6.3 to v3.6.4, indicating a minor page update. This is unlikely to affect the study details or eligibility criteria.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision label on the page was updated from v3.6.2 to v3.6.3 to reflect a new build of the ClinicalTrials.gov page.SummaryDifference0.1%

Stay in the know with updates to Psilocybin for Alcohol Use Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Alcohol Use Disorder Clinical Trial page.